Patents by Inventor Pascal TAULELLE

Pascal TAULELLE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORMS OF A RYANODINE RECEPTOR MODULATOR AND USES THEREOF
    Publication number: 20230075141
    Abstract: The present disclosure relates to crystalline forms of the compound 4-[(7-methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)yl)methyl]benzoic acid hemifumarate, pharmaceutical compositions comprising these compounds and uses thereof to treat diseases and conditions associated with Ryanodine Receptor (RyR) dysfunction, in particular cardiac and musculoskeletal disorders and diseases.
    Type: Application
    Filed: October 17, 2022
    Publication date: March 9, 2023
    Inventors: Pascal TAULELLE, Sandro BELVEDERE
  • CRYSTALLINE FORMS OF A RYANODINE RECEPTOR MODULATOR AND USES THEREOF
    Publication number: 20230069022
    Abstract: The present disclosure relates to crystalline forms of the compound 4-[(7-methoxy-2,3-dihydro-1, 4-benzothiazepin-4(5H)yl)methyl]benzoic acid hemifumarate, pharmaceutical compositions comprising these compounds and uses thereof to treat diseases and conditions associated with Ryanodine Receptor (RyR) dysfunction, in particular cardiac and musculoskeletal disorders and diseases.
    Type: Application
    Filed: October 17, 2022
    Publication date: March 2, 2023
    Inventors: Pascal TAULELLE, Sandro BELVEDERE
  • Crystalline forms of a Ryanodine receptor modulator and uses thereof
    Patent number: 11504383
    Abstract: The present disclosure relates to crystalline forms of the compound 4-[(7-methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)yl)methyl]benzoic acid hemifumarate, pharmaceutical compositions comprising these compounds and uses thereof to treat diseases and conditions associated with Ryanodine Receptor (RyR) dysfunction, in particular cardiac and musculoskeletal disorders and diseases.
    Type: Grant
    Filed: January 7, 2022
    Date of Patent: November 22, 2022
    Assignee: ARMGO PHARMA, INC.
    Inventors: Pascal Taulelle, Sandro Belvedere
  • CRYSTALLINE FORMS OF A RYANODINE RECEPTOR MODULATOR AND USES THEREOF
    Publication number: 20220226344
    Abstract: The present disclosure relates to crystalline forms of the compound 4-[(7-methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)yl)methyl]benzoic acid hemifumarate, pharmaceutical compositions comprising these compounds and uses thereof to treat diseases and conditions associated with Ryanodine Receptor (RyR) dysfunction, in particular cardiac and musculoskeletal disorders and diseases.
    Type: Application
    Filed: January 7, 2022
    Publication date: July 21, 2022
    Inventors: Pascal TAULELLE, Sandro BELVEDERE
  • NOVEL SALT OF A BCL-2 INHIBITOR, RELATED CRYSTALLINE FORM, METHOD FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
    Publication number: 20210355108
    Abstract: Novel salt and related crystalline forms of Compound A: wherein the salt is the hydrogen sulfate salt, characterised by its X-ray powder diffraction diagram, method for preparing the same and pharmaceutical compositions containing it.
    Type: Application
    Filed: October 30, 2019
    Publication date: November 18, 2021
    Inventors: Michael LYNCH, Frédéric VILLARD, Patrick MOUCHET, Pascal TAULELLE, Ludovic MASSON